To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus

NCT03495765 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
160
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Marsden Eye Specialists